✦ LIBER ✦

Antinuclear antibodies in scleroderma, mixed connective tissue disease and “primary” Raynaud's phenomenon

✍ Scribed by M. Cruz; G. Mejia; C. Lavalle; J. J. Cortes; P. A. Reyes

Publisher: Springer
Year: 1988
Tongue: English
Weight: 46 KB
Volume: 7
Category: Article
ISSN: 0770-3198
DOI: 10.1007/bf02204468

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antinuclear antibodies in scleroderma, m

Antinuclear antibodies in scleroderma, mixed connective tissue disease and “primary” Raynaud's phenomenon

✍ M. Cruz; G. Mejia; C. Lavalle; J. J. Cortes; P. A. Reyes 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 529 KB

Evolution of primary raynaud's phenomeno

Evolution of primary raynaud's phenomenon (raynaud's disease) to connective tissue disease

✍ David D. Gerbracht; Virginia D. Steen; Gayle L. Ziegler; Thomas A. Medsger Jr.; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Raynaud’s phenomenon in undifferentiated

Raynaud’s phenomenon in undifferentiated connective tissue disease (UCTD)

✍ Rossella De Angelis; Angela Cerioni; Patrizia Del Medico; Patrizia Blasetti 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 221 KB

Measurement of soluble adhesion molecule

Measurement of soluble adhesion molecules in primary Raynaud’s phenomenon and in Raynaud’s phenomenon secondary to connective tissue diseases

✍ G. Brevetti; M. De Caterina; V. D. Martone; S. Corrado; A. Silvestro; G. Spadaro 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 556 KB

Comparison of the complement-fixing acti

Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma

✍ Michael Dean Parker; Robert A. Turner 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB 👁 2 views

Antilymphocytic antibodies in mixed conn

Antilymphocytic antibodies in mixed connective tissue disease

✍ Efraín Díaz-Jouane; Donato Alarcó-Segovia 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

alleles may actually operate against its formation. Alternatively, it is possible that immune response genes which promote antibodies to nRNP may not be represented on DRZlMBl/MTl and DR3/MT2 bearing haplotypes. Thus, the presence of both sets of alleles, as seen in our patients, might exclude this